ORAL ADMINISTRATION OF EPIGALLOCATECHIN-3-GALLATE (EGCG) IS A POTENTIAL THERAPEUTIC FOR CISPLATIN-INDUCED HEARING LOSS
Cisplatin is a commonly used chemotherapeutic agent for multiple solid tumors. However, cisplatin-induced neurotoxicity, nephrotoxicity and hearing loss hamper its use in clinical setting. Although, neurotoxicity and nephrotoxicity can be prevented, there is no cure for cisplatin-induced hearing los...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
OpenSIUC
2017
|
| Subjects: | |
| Online Access: | https://opensiuc.lib.siu.edu/dissertations/1487 https://opensiuc.lib.siu.edu/cgi/viewcontent.cgi?article=2491&context=dissertations |